MXPA02004619A - Metodo para tratar enfermedades virales y otros trastornos, alterando la expresion del gen inmediato mediante la administracion del peptido t. - Google Patents
Metodo para tratar enfermedades virales y otros trastornos, alterando la expresion del gen inmediato mediante la administracion del peptido t.Info
- Publication number
- MXPA02004619A MXPA02004619A MXPA02004619A MXPA02004619A MXPA02004619A MX PA02004619 A MXPA02004619 A MX PA02004619A MX PA02004619 A MXPA02004619 A MX PA02004619A MX PA02004619 A MXPA02004619 A MX PA02004619A MX PA02004619 A MXPA02004619 A MX PA02004619A
- Authority
- MX
- Mexico
- Prior art keywords
- thr
- residu
- carboxy
- est
- ser
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se describe un metodo para inhibir la replicacion viral y para tratar las condiciones neurotroficas, al regular/inhibir la expresion del gen inmediato temprano en celulas hospederas que comprende administrarle una cantidad inhibitoria/reguladora efectiva de un Peptido de la Formula (I). Ra-Ser-Thr-Thr-Thr-Asn-Tyr-Rb en donde Ra representa un residuo terminal amino Ala- o D- Ala y Rb representan un residuo terminal carboxilo -Thr o - Thr-amida o un derivado de estos con un residuo adicional Cys- en una o ambas de las terminales amino y carboxilo, o un Peptido de la Formula (II): R1-R2-R3-R4-R5 en donde R1 es un residuo terminal amino Thr-, Ser-, Asn-, Glu-, Arg-, Ile- o Leu-, R2 es Thr, Ser, o Asp, R3 es Thr, Ser, Asn, Arg, Gln, Lys, o Trp, R4 es Tyr y R5 es preferiblemente un residuo terminal carboxilo -Thr, -Arg o Gly un derivado de estos con un D-aminoacido correspondiente como el residuo terminal amino, y/o un derivado amida correspondiente en el residuo terminal carboxilo y/o adicionalmente un residuo Cys- en una o ambas de las terminales amino y carboxilo, en un portador fisiologicamente adecuado.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16436399P | 1999-11-09 | 1999-11-09 | |
| PCT/US2000/042030 WO2001034095A2 (en) | 1999-11-09 | 2000-11-09 | A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02004619A true MXPA02004619A (es) | 2004-09-10 |
Family
ID=22594146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02004619A MXPA02004619A (es) | 1999-11-09 | 2000-11-09 | Metodo para tratar enfermedades virales y otros trastornos, alterando la expresion del gen inmediato mediante la administracion del peptido t. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1242109A4 (es) |
| JP (1) | JP2003528817A (es) |
| KR (1) | KR20020063182A (es) |
| CN (1) | CN1635913A (es) |
| AU (1) | AU3080001A (es) |
| CA (1) | CA2389392A1 (es) |
| IL (1) | IL149443A0 (es) |
| MX (1) | MXPA02004619A (es) |
| WO (1) | WO2001034095A2 (es) |
| ZA (1) | ZA200203120B (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6242564B1 (en) * | 1986-06-03 | 2001-06-05 | Candace B. Pert | Treatment of tropical spastic paresis with peptide T |
| ES2222625T3 (es) * | 1992-03-27 | 2005-02-01 | Advanced Immuni T, Inc. | Peptido t y peptidos asociados destinados al tratamiento de la inflamacion incluyendo la esclerosis multiple. |
-
2000
- 2000-11-09 KR KR1020027006014A patent/KR20020063182A/ko not_active Application Discontinuation
- 2000-11-09 IL IL14944300A patent/IL149443A0/xx unknown
- 2000-11-09 WO PCT/US2000/042030 patent/WO2001034095A2/en not_active Application Discontinuation
- 2000-11-09 MX MXPA02004619A patent/MXPA02004619A/es unknown
- 2000-11-09 CN CNA008154821A patent/CN1635913A/zh active Pending
- 2000-11-09 EP EP00990995A patent/EP1242109A4/en not_active Withdrawn
- 2000-11-09 JP JP2001536100A patent/JP2003528817A/ja active Pending
- 2000-11-09 CA CA002389392A patent/CA2389392A1/en not_active Abandoned
- 2000-11-09 AU AU30800/01A patent/AU3080001A/en not_active Abandoned
-
2002
- 2002-04-19 ZA ZA200203120A patent/ZA200203120B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1242109A2 (en) | 2002-09-25 |
| CN1635913A (zh) | 2005-07-06 |
| IL149443A0 (en) | 2002-11-10 |
| WO2001034095A2 (en) | 2001-05-17 |
| CA2389392A1 (en) | 2001-05-17 |
| KR20020063182A (ko) | 2002-08-01 |
| AU3080001A (en) | 2001-06-06 |
| EP1242109A4 (en) | 2004-06-02 |
| WO2001034095A8 (en) | 2001-11-29 |
| JP2003528817A (ja) | 2003-09-30 |
| ZA200203120B (en) | 2002-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106573955B (zh) | 位点特异性蛋白质修饰 | |
| NO20053761L (no) | Parenterale peptidformuleringer for behandling av systemisk lupus erythematosus. | |
| JO3404B1 (ar) | تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين | |
| EA200300381A1 (ru) | Нуклеиновые кислоты и полипептиды нового рецептора | |
| NO335730B1 (no) | Polypeptid og farmasøytisk sammensetning, samt anvendelse derav. | |
| JPH07504679A (ja) | グルカゴン様ペプチド及びインシュリノトロピン誘導体 | |
| MY129234A (en) | Oral pharmaceutical forms of administration with a delayed action with tramadol. | |
| WO2002005748A3 (en) | Medicinal uses of mu-opioid receptor agonists | |
| US5457047A (en) | DNA Sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition | |
| EA200501131A1 (ru) | Парентеральные композиции пептидов для лечения системной красной волчанки | |
| JP2024503508A (ja) | 免疫調節性抗体－薬物コンジュゲート | |
| BG66393B1 (bg) | Полимерни конюгати на неубластин и методи за тяхното използване | |
| HUT77979A (hu) | Peptidek, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
| MXPA02004619A (es) | Metodo para tratar enfermedades virales y otros trastornos, alterando la expresion del gen inmediato mediante la administracion del peptido t. | |
| JP2023549229A (ja) | トランスフェリン受容体１（ＴｆＲ１）に特異的な二環式ペプチドリガンド | |
| EP0579363B1 (en) | Treatment of tropical spastic paresis with peptide T | |
| KR100699404B1 (ko) | 성장 호르몬 분비촉진제로서의 신규 아미드 유도체 | |
| JP6656661B2 (ja) | プレキシンの結合調節剤 | |
| EP0815870A2 (en) | Composition for prohylaxis or treatment of cerebral infarction | |
| US5698672A (en) | Synthetic calcitonin mimetics | |
| US20060189536A1 (en) | Treating the effects of nicotine | |
| US9907860B2 (en) | Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to an anionic polypeptide for the treatment of AIDS | |
| CU23538B7 (es) | Composiciones farmacéuticas para el tratamiento de enfermedades relacionadas a neurotrofinas | |
| EA200400691A1 (ru) | Получение чистых стереоизомеров трицикло[5,2,1,02,6]дец-9-ил-ксантогената и содержащие их лекарственные средства | |
| JP2004107333A5 (es) |